|
|
|
Weekly Market: Global chaos drag markets lower for the week
|
|
Friday, August 21, 2015 |
| | | Market Commentary | | | Global chaos drag markets lower for the week | | Indian markets wrapped up the week ended August 21, 2015 in the red zone led by weak global environment. The Sensex was down 2.50% and the Nifty fell 2.57%. | |
 Major Headlines for the week:
Indian indices:
Welcome to the 'Weekly Market Wrap' for Friday, August 21, 2015, where key benchmark indices dropped sharply on weak global cues. The market logged declines in four out of five trading sessions in the week just gone by. The barometer index, the S&P BSE Sensex, fell below the psychological 28,000 mark. Key indices fell in four out of five trading sessions of the week. The S&P BSE Mid-Cap index dropped 2.07% while S&P BSE Small-Cap index lost 1.32%. The drop in both these indices was lower than the Sensex's decline in percentage terms.
World equity markets and emerging market currencies have recently witnessed selling pressure as investors fretted over slowdown in China's economic growth. China's decision last week to devalue its yuan has intensified investor concerns that weakness in the world's second-largest economy will crimp global growth, particularly among China's northern Asian competitors in the exports market.
The S&P BSE Sensex tumbled 701.24 points or 2.50% to settle at 27,366.07 in the week ended 21 August 2015. The 50-unit CNX Nifty lost 218.60 points or 2.57% to settle at 8,299.95.
Weekly market trend from August 17, 2015 - August 21, 2015:
August 17- Indian shares fell on Monday, led by selling in blue chip stocks as weak Asian markets, a lacklustre parliament session and the absence of any positive earnings trigger weighed on sentiment. The S&P BSE Sensex and CNX Nifty ended 0.67%-0.48% lower each. The Sensex ended below the 28,000 mark at 27,878, lower by 189 points and Nifty settled at 8,477, down 41 points.
August 18- Indian shares ended lower in choppy trade on Tuesday as investors pared positions on risk aversion after a steep fall in Chinese equities, and on worries at home that the monsoon may be deficient. The S&P BSE Sensex and CNX Nifty ended 0.17%-0.13% lower each. The 30-share Sensex ended down 47 points at 27,832 and the Nifty ended 11 points lower at 8,467.
August 19- Indian shares rose on Wednesday, led by gains in export-focussed companies after the rupee fell to a near two-year low, while bullish brokerage calls also helped drugmakers such as Sun Pharmaceutical Industries. The S&P BSE Sensex and CNX Nifty ended 0.36%-0.34% higher each. The Sensex closed 100 points higher at 27,932 levels and the Nifty gained 29 points to end at 8,495.
August 20- India's NSE index fell about 1.5 percent amid global risk aversion, while Infosys declined on speculation that it may announce acquisitions which may weigh on its earnings. The S&P BSE Sensex and CNX Nifty ended 1.16%-1.44% lower each. The BSE Sensex ended at 27,607, lower by 323 points or 1.1% and the Nifty settled at 8,371, down 122 points.
August 21- Indian shares fell on Friday to their lowest close in two months, as fears of a China-led  deceleration in global growth and escalating tension between South Korea and North Korea gripped markets. The S&P BSE Sensex and CNX Nifty ended 0.88%-0.87% lower each. The S&P barometer BSE Sensex ended 242 points down at 27,366 and the CNX Nifty barely finished at 8,300, down by 73 points.
Global indices:
All the Global indices ended in red. The topmost losers were: S&P BSE Shanghai Composite down 11.54%, Hang Seng down 6.59%, Dax100 down 5.29%, Nikkei down 5.28% and CAC40 down 4.08%.
 Sectoral and stock screening:
Among 13 Sectoral Indices: Top Gainer: S&P BSE HC gained 2.11%, S&P BSE CD gained 1.39% and S&P BSE FMCG gained 1.10%. Top Losers: S&P BSE Realty down 9.00%, S&P BSE Metal down 5.20% and S&P BSE Oil&Gas down 3.77%.
| | Looking at the 'A' group stocks, the top three gainers of the week were: SREI Infrastructure Finance up 17.82%, Delta Corp up 14.90% and Atul up 11.15%
Top three losers of the week were: Kaveri Seed Company down 22.17%, Central Bank of India down 22.09% and Vakrangee down 18.91%
FII/MF activity:
The foreign institutional investors (FIIs) have been the net buyers of the Indian stocks to the tune of Rs19.38 crore as on August 17, 2015 and the domestic investors bought Indian shares worth a net of Rs150.90 crore as on August 18, 2015.
| | TOP MOVERS (GROUP A) |  | | | | | | | | | | | | | | | | Kaveri Seed Company | 468.40 | -22.17 | | | Central Bank of India | 80.60 | -22.09 | | | | | | | | | FII/MF ACTIVITIES | | | | | | | Gross purchase | 6,977.71 | 1,598.80 | | | Gross sale | 6,958.33 | 1,447.90 | | | Net investment | 19.38 | 150.90 | | | | | | | | *Data as on August 17, 2015
**Data as on August 18, 2015 | | | | Market Outlook for the coming week!
In the coming week, macroeconomic data, the progress of monsoon rains, trend in global markets, investment by foreign portfolio investors (FPIs), the movement of rupee against the dollar and crude oil price movement will dictate trend on the bourses.
The market may remain volatile as traders roll over positions in the futures & options (F&O) segment from the near month August 2015 series to September 2015 series.
The near month August 2015 derivatives contracts are set to expire on Thursday, 27 August 2015. | | | | To know more about our products and services, click here. |  | REGISTRATION DETAILS Regd Add: Sharekhan Limited, 10th Floor, Beta Building, Lodha iThink Techno Campus, Off. JVLR, Opp. Kanjurmarg Railway Station, Kanjurmarg (East), Mumbai - 400042, Maharashtra. Tel: 022 - 61150000. Sharekhan Ltd.: SEBI Regn. Nos. BSE - INB/INF011073351 ; BSE- CD ; NSE - INB/INF231073330 ; CD-INE231073330 ; MCX Stock Exchange - INB/INF261073333 ; CD-INE261073330 ; DP - NSDL-IN-DP-NSDL-233-2003 ; CDSL-IN-DP-CDSL-271-2004 ; PMS-INP000000662 ; Mutual Fund-ARN 20669 ; Commodity trading through Sharekhan Commodities Pvt. Ltd.: MCX-10080 ; (MCX/TCM/CORP/0425) ; NCDEX-00132 ; (NCDEX/TCM/CORP/0142) ; NCDEX SPOT-NCDEXSPOT/116/CO/11/20626 ; For any complaints email at igc@sharekhan.com ; Disclaimer: Client should read the Risk Disclosure Document issued by SEBI & relevant exchanges and Do's & Don'ts by MCX & NCDEX and the T & C on www.sharekhan.com before investing. | | | | "This document has been prepared by Sharekhan Ltd. (SHAREKHAN) and is intended for use only by the person or entity to which it is addressed to. This document may contain confidential and/or privileged material and is not for any type of circulation and any review, retransmission, or any other use is strictly prohibited. This document is subject to changes without prior notice. This document does not constitute an offer to sell or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Though disseminated to all customers who are due to receive the same, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is obtained from publicly available data or other sources believed to be reliable and SHAREKHAN has not independently verified the accuracy and completeness of the said data and hence it should not be relied upon as such. While we would endeavour to update the information herein on a reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees ("SHAREKHAN and affiliates") are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. This document is prepared for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. Recipients of this report should also be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as he deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult his own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of SHAREKHAN may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licencing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. Either SHAREKHAN or its affiliates or its directors or employees/representatives/clients or their relatives may have position(s), make market, act as principal or engage in transactions of purchase or sell of securities, from time to time or may be materially interested in any of the securities or related securities referred to in this report and they may have used the information set forth herein before publication. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. The analyst certifies that all of the views expressed in this document accurately reflect his or her personal views about the subject company or companies and its or their securities and do not necessarily reflect those of SHAREKHAN. Further, no part of the analyst's compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this document." Compliance Officer: Ms. Namita Amod Godbole; Tel: 022-6115000; e-mail: compliance@sharekhan.com
Contact: myaccount@sharekhan.com | | | |
|
posted by Anonymous @ 1:01 PM  |
|
|
|
|
|
